Suppr超能文献

光化性唇炎的激光介导光动力疗法。

Laser-mediated photodynamic therapy of actinic cheilitis.

作者信息

Alexiades-Armenakas Macrene R, Geronemus Roy G

机构信息

Yale University School of Medicine, Department of Dermatology, New Haven, CT, USA.

出版信息

J Drugs Dermatol. 2004 Sep-Oct;3(5):548-51.

Abstract

Actinic cheilitis (AC) is a common precancerous condition for which a safe, effective, rapid, and cosmetically favorable treatment is needed. The objective of this study was to assess the safety and efficacy of the long-pulsed pulsed dye laser (LP PDL) (595 nm) with photodynamic therapy (PDT) for the treatment of AC. This study was designed to be a prospective, proof-of concept pilot study to assess safety and efficacy of LP PDL in conjunction with topical 20% 5-aminolevulinic acid solution PDT for the treatment of AC. Control patients received LP PDL alone. The setting was an outpatient clinical research center. A volunteer sample of 21 patients with biopsy-proven AC was enrolled (age range, 42-86 years; skin types I-III). All patients were refractory to prior therapies. Patients with a history of herpes labialis were pre-treated with famcyclovir. Nineteen patients received one-to-three treatments of topical 20% 5-aminolevulinic acid for 2-3 hours, followed by LP PDL (595 nm) at monthly intervals. Two control patients received one treatment with LP PDL alone. Patients in the ALA-LP PDL group were followed at 1, 2, 3, 6, 9, and 12 months. Clearance of AC was assessed by clinical evaluation. Control patients were followed to the one month interval. We observed none-to-mild pain; slight-to-moderate erythema; no crusting, purpura, or scarring; treatment time of less than one minute; and complete resolution of post-operative erythema by day three. Complete clearance was achieved in 13/19 (68%) of patients following a mean of 1.8 treatments (7/13 (37%) after one, 2/13 (11%) after two, and 1/13 (21%) after three treatments). Patients were followed for a mean of 4.1 (range 1-12) months. Among the remaining cases, partial clearing was achieved in two patients, recurrence during the follow-up interval was observed in one patient, and failure to follow-up occurred in three patients. Post-operative impetiginization occurred in three patients with erosive AC, which resolved with dicloxacillin therapy. Among the control patients, no clearing was observed. Treatment of AC using LP PDL (595 nm) at nonpurpuric parameters following topical application of 5-aminolevulinic acid at short incubation times is safe and effective. It may offer the advantages of rapid incubation, treatment, and recovery times, minimal discomfort, excellent cosmetic outcome, and good efficacy rates. Patients with erosive AC should receive antibacterial prophylaxis. Multiple treatments may be required for complete clearing.

摘要

光化性唇炎(AC)是一种常见的癌前病变,需要一种安全、有效、快速且美观效果良好的治疗方法。本研究的目的是评估长脉冲染料激光(LP PDL)(595nm)联合光动力疗法(PDT)治疗AC的安全性和有效性。本研究设计为一项前瞻性概念验证性初步研究,以评估LP PDL联合局部20% 5-氨基酮戊酸溶液PDT治疗AC的安全性和有效性。对照组患者仅接受LP PDL治疗。研究地点为门诊临床研究中心。招募了21例经活检证实为AC的志愿者样本(年龄范围42 - 86岁;皮肤类型I - III)。所有患者对先前治疗均无效。有唇疱疹病史的患者预先用泛昔洛韦治疗。19例患者接受1 - 3次局部20% 5-氨基酮戊酸治疗2 - 3小时,随后每月进行一次LP PDL(595nm)治疗。2例对照患者仅接受1次LP PDL治疗。ALA - LP PDL组患者在1、2、3、6、9和12个月时进行随访。通过临床评估评估AC的清除情况。对照患者随访至1个月间隔。我们观察到无至轻度疼痛;轻度至中度红斑;无结痂、紫癜或瘢痕形成;治疗时间少于1分钟;术后红斑在第3天完全消退。19例患者中有13例(68%)在平均1.8次治疗后实现完全清除(1次治疗后7例(37%),2次治疗后2例(11%),3次治疗后1例(21%))。患者平均随访4.1(范围1 - 12)个月。其余病例中,2例患者部分清除,1例患者在随访期间复发,3例患者未进行随访。3例糜烂性AC患者术后发生脓疱病,经双氯西林治疗后痊愈。在对照患者中,未观察到清除情况。在短孵育时间局部应用5-氨基酮戊酸后,以非紫癜性参数使用LP PDL(595nm)治疗AC是安全有效的。它可能具有孵育、治疗和恢复时间短、不适最小、美容效果极佳以及有效率高的优点。糜烂性AC患者应接受抗菌预防。可能需要多次治疗才能完全清除。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验